---
title: "AlzChem H1 FY26 EBITDA climbs 14% to EUR 64.5 million; revenue rises 6% to EUR 303.9 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294302297.md"
description: "AlzChem Group reported H1 FY26 revenue of EUR 303.9 million, up 6%, with EBITDA rising 14% to EUR 64.5 million and margin widening to 21.2%. Specialty Chemicals drove growth with a 10% revenue increase, while Basics & Intermediates saw a slight decline. The company reiterated its 2026 outlook and secured new long-term financing of up to EUR 100 million for growth projects."
datetime: "2026-07-30T04:55:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294302297.md)
  - [en](https://longbridge.com/en/news/294302297.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294302297.md)
generator: "portal-rs"
---

# AlzChem H1 FY26 EBITDA climbs 14% to EUR 64.5 million; revenue rises 6% to EUR 303.9 million

-   AlzChem posted H1 2026 revenue up 6% to EUR 303.9 million. \* EBITDA climbed 14% to EUR 64.5 million; the EBITDA margin widened 1.6 percentage points to 21.2%. \* Specialty Chemicals revenue rose 10% to EUR 214.3 million; EBITDA increased 19% to EUR 64.1 million. \* Basics & Intermediates revenue slipped 3.6% to EUR 75.4 million; EBITDA swung to break-even. \* Outlook for 2026 reiterated; new long-term financing agreed for up to EUR 100 million to fund growth projects. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzChem Group AG published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ACT.DE](https://longbridge.com/en/quote/ACT.DE.md)

## Related News & Research

- [ACT: Strong H1 2026 growth driven by Specialty Chemicals, with guidance confirmed and expansions on track](https://longbridge.com/en/news/294338478.md)
- [ACT: Specialty Chemicals drove double-digit profit growth in H1 2026, with robust outlook confirmed](https://longbridge.com/en/news/294303733.md)
- [Lottomatica guides 2026 adjusted EBITDA at €940 million-€980 million](https://longbridge.com/en/news/297735216.md)
- [ERG confirms 2026 adjusted EBITDA guidance of €520-590 million](https://longbridge.com/en/news/297804769.md)
- [Cantourage sees FY2026 revenue EUR 85 million-95 million, adjusted EBITDA EUR 10 million-12 million](https://longbridge.com/en/news/297475521.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**